Neuropilin-1 (Nrp1), a transmembrane protein involved in establishing the immunological synapse, is required for the initiation of a primary immune response. Although largely studied as a regulatory T cell (Treg) marker, Nrp1 is expressed on activated/memory T cells. Nrp1 expression on conventional CD4+ T cells (Foxp3-) has a strong positive correlation with islet infiltration in non-obese diabetic (NOD) mice and with cytotoxic T cell development in an acute alloresponse mouse model. In these models, Nrp1 expression is reduced on CD4+Foxp3- cells following aryl hydrocarbon receptor (AhR) activation. AhR, a ligand-activated transcription factor, leads to regulation of CD4+ T cell responses through mechanisms not fully understood. To better understand the link between AhR and Nrp1 expression on CD4+ T cells, Nrp1 expression was assessed in vivo and in vitro following AhR ligand treatment. The actively dividing Nrp1+Foxp3- cells expressing the classic effector phenotype of CD44hiCD45RBlo increase over the course of the alloresponse which is prevented by AhR activation. AhR activation prevents Nrp1 upregulation on only activated CD4+ T cells as the expression of Nrp1 in non-responding CD4+ T cells is unchanged by AhR ligands. This prevention could be recapitulated in vitro in CD4+ T cells isolated from C57BL/6 or NOD mice. AhR activation did not reduce expression of the activation markers CD69, CD29, and CD25. Instead, CD25 cells were particularly sensitive to AhR-mediated inhibition of Nrp1 upregulation. Specifically, anti-CD3/C28 activated CD4+ T cells stimulated with IL-2, or differentiated into Th1, Th17, or Treg subsets, significantly lowered Nrp1 expression in the presence of an AhR ligand compared to vehicle-treated cells; the largest differential expression at the protein and gene level was observed in Th1 cells while expression was unchanged in Th2 differentiated cells. In cells from AhR knockout mice, the reduction in Nrp1 expression was not observed with CD4+ T cells. As the regulation of Nrp1 expression was pronounced in CD25+ cells in vitro, the role of IL-2 in mediating Nrp1 downregulation was assessed. In vivo and in vitro, AhR ligands no longer prevented the upregulation of Nrp1 when excess IL-2 was neutralized during the alloresponse. Collectively, the data demonstrate that Nrp1 is a CD4+ T cell activation marker and that regulation of Nrp1 could be a mechanism by which AhR ligands lead to immune suppression of CD4+ T cell responses.